Israel vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Israel
100.0%
in 2024
Sur
82.0%
in 2024
Israel rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Israel
- Sur
How they compare
Israel currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Israel's figure about 1.2 times Sur's.
The two have swapped places 4 times across 12 shared years of data; in 2008 it was Israel ahead.
Israel ranks 1st and Sur ranks 2nd of 144 countries.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Israel | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 68.0% | 41.0% | 27.0% | Israel |
| 2010s | 100.0% | 72.2% | 27.8% | Israel |
| 2020s | 98.2% | 75.8% | 22.4% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Israel or Sur?
- Israel, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Israel and Sur?
- 18.0%, with Israel ahead.
- How many years of comparable data are there for Israel and Sur?
- 12 years are reported by both, from 2008 to 2024.
- How do Israel and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Israel ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.